DistantNews
Support us
🇨🇭 Switzerland /Health & Science

WHO submits Ebola treatment trial protocols to DRC and Uganda

From Le Temps · () French

Translated from French and summarized by DistantNews. Read the original for the full story.

At a glance

News Named sources Context piece
  • The World Health Organization is considering a clinical trial for two potential Ebola treatments, MBP134 and remdesivir, targeting the Bundibugyo strain.
  • Protocols for the trial have been submitted to authorities in the Democratic Republic of Congo and Uganda for review and approval.
  • Currently, there are no approved treatments or vaccines for this specific strain of Ebola, with 51 confirmed and over 600 suspected cases reported.

The World Health Organization is taking a crucial step in combating the Ebola Bundibugyo strain by proposing a unique clinical trial. This trial aims to evaluate two promising treatments: a monoclonal antibody known as MBP134 and the antiviral remdesivir.

The protocols have been submitted to the Democratic Republic of Congo and Uganda, the nations most directly affected by this outbreak. The decision to proceed now rests with their national authorities and local ethics committees, highlighting the importance of national sovereignty in public health decisions.

A unique clinical trial involving two potential treatments for the Ebola Bundibugyo virus is currently under consideration. It plans to test a monoclonal antibody against this virus, MBP134, as well as an antiviral, remdesivir.

· WHO spokespersonConfirming the details of the proposed clinical trial to Le Temps.

With 51 confirmed cases and over 600 suspected infections, the urgency is clear. The absence of any approved treatments or vaccines for this particular strain underscores the significance of this potential trial. This initiative represents a beacon of hope in a challenging health crisis, demonstrating a commitment to finding effective solutions for affected populations.

The decision to give or not give the green light rests with the national authorities and local ethics committees of each country.

· WHO spokespersonExplaining the process for approving the clinical trial in the DRC and Uganda.
About this summary

Originally published by Le Temps in French. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.

More Stories

From Our Blog